A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia
Journal of Critical Limb Ischemia · 2025
DOI: 10.25270/jcli/clig-2400010 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Critical Limb Ischemia, 2025. Verfasst von Khanjan Nagarsheth und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Peripheral arterial disease is a growing global burden, with chronic limb-threatening ischemia (CLTI), its most advanced stage, associated with high morbidity, mortality, and economic costs. While randomized controlled trials are the gold standard for evaluating treatment strategies, their external validity is often limited by strict inclusion criteria that exclude complex, real-world patients with CLTI. Lesion and device characteristics further complicate trial generalizability, with registries providing more representative insights. Recent trials highlight the challenges of translating trial findings to clinical practice. This review underscores the need for evidence-based pathways tailored to real-world CLTI populations.
Zitieren
APA
Nagarsheth, K., Jreij, G., & Saab, F. (2025). A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia. Journal of Critical Limb Ischemia. https://doi.org/10.25270/jcli/clig-2400010
Vancouver
Nagarsheth K, Jreij G, Saab F. A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia. Journal of Critical Limb Ischemia. 2025. doi:10.25270/jcli/clig-2400010
BibTeX
@article{Nagarsheth2025,
author = {Nagarsheth, Khanjan and Jreij, Georges and Saab, Fadi},
title = {A Systematic Review of Clinical Trials in Patients With Critical Limb-Threatening Ischemia},
journal = {Journal of Critical Limb Ischemia},
year = {2025},
doi = {10.25270/jcli/clig-2400010}
}
EUVIMED